OVERVIEW
The most common complaint causing a person to seek the services of a health care provider is pain or the closely associated symptom, discomfort. Consequently, the primary obligation and ultimate responsibility of every practitioner of the healing arts is not only to restore health but also to relieve pain. The intent of this course is to present clinicians a rational strategy for the medical management of acute odontogenic pain and to discuss current recommendations for the use of local anesthetic agents and analgesics.

GENERAL OBJECTIVES
Participants in this course will be introduced to evidence-based information that will help them to select the most appropriate therapeutic intervention for the management of acute odontogenic pain and when pharmacotherapy is indicated, to prescribe dose enough, soon enough, often enough, long enough---to prescribe, as they would receive.

LEARNING OBJECTIVES
Upon completion of this course the practitioner should be able to:
• Discuss the basic mechanisms of acute pain.
• Discuss the pharmacological basis of and factors to be considered in the selection of a local anesthetic agent.
• Discuss the pharmacological basis of and factors to be considered in the selection of a COX-1, COX-2, and COX-3 inhibitor.
• Discuss the pharmacological basis of and factors to be considered in the selection of a combination analgesic.

ANTIBACTERIAL AGENTS
Use and Misuse

OVERVIEW
Most infections of the head and neck region are odontogenic in origin, which can be resolved satisfactorily through an approach that incorporates appropriate, timely debridement (primary dental care). Odontogenic infections, which fail to respond to debridement, may spread into anatomical spaces contiguous with fascial planes and lead to serious, even life-threatening situations especially in immunocompromized patients. The intent of this course is to present clinicians a rational strategy for the medical management of odontogenic infections and to discuss current recommendations for the use of antibacterial prophylaxis.

OBJECTIVES
Participants in this course will be introduced to evidence-based information that will help them to select the most appropriate therapeutic intervention for the management of an odontogenic
infection considering the diagnosis, the need for antibacterial chemotherapy or antibacterial prophylaxis, the benefits versus the risks of drug therapy, the need to individualize drug regimen, the need for educating patients, and the importance of follow-up.

OBJECTIVES
Upon completion of this course the practitioner should be able to:
• Discuss the etiology of odontogenic infections.
• Discuss the pharmacological basis of antibacterial chemotherapy in dentistry.
• Develop appropriate strategies for the medical management of odontogenic infections.
• Recognize indications and contraindications for the use of antibacterial prophylaxis.
• Understand the clinical relevance of antibacterial drug resistance.

PRESENTER
GEZA T. TEREZHALMY, D.D.S., M.A., received his DDS degree from Case Western Reserve University in 1971, continuing with his postgraduate training from 1975 to 1977 and obtaining a Certificate in Oral Medicine from the National Naval Dental Center. In 1987, he obtained his MA degree in Higher Education and Human Development from The George Washington University. Dr. Terezhalmy is the Endowed Professor in Clinical Dentistry in the Department of Dental Diagnostic Science with a cross appointment in the Department of Pharmacology in the Graduate School of Biomedical Sciences at The University of Texas Health Science Center at San Antonio.

TIME
Check-in & Breakfast: South Padre Island Convention Center, 8:00 AM,
Program: Friday, 9:00 AM–5:00 PM

LOCATION
South Padre Island Convention Center
7355 Padre Boulevard
South Padre Island, Texas 78597
(956) 761-3000

Website: www.sopadre.com

TUITION
First Office Member: $209.50
Each Additional Office Member: $149.50

CREDIT (Course Code: 124396A) • AGD Code: 730 Hours: 7